Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Invivyd, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 70 | 1 | 57 | −12 |
| Shares | 59.9M | 35.2K | 55.9M | −4.00M (−6.7%) |
| Value | $71.9M | $42.2K | $58.7M | −$13.2M (−18.3%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Invivyd, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RBF Capital, LLC | 203,683 | $213.9K | 0.01% |
| BML Capital Management, LLC | 134,696 | $141.4K | 0.13% |
| Verition Fund Management LLC | 132,462 | $139.1K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 111,936 | $117.5K | 0.01% |
| Qube Research & Technologies Ltd | 75,530 | $79.3K | 0.00% |
| Old Mission Capital LLC | 43,316 | $45.5K | 0.00% |
| Cubist Systematic Strategies, LLC | 29,811 | $31.3K | 0.00% |
| Balyasny Asset Management LLC | 13,056 | $13.7K | 0.00% |
| Gladius Capital Management LP | 11,910 | $12.5K | 0.01% |
| Point72 Asset Management, L.P. | 8,920 | $9.37K | 0.00% |
| Nisa Investment Advisors, LLC | 6 | $6 | 0.00% |
Sold out (23)
Institutions that held Invivyd, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Nuveen Asset Management, LLC | 203,878 | $244.0K |
| Susquehanna International Group, LLP | 52,061 | $62.5K |
| Price T Rowe Associates Inc | 46,639 | $56.0K |
| Alliancebernstein L.P. | 39,900 | $47.9K |
| Barclays PLC | 26,104 | $31.3K |
| Prelude Capital Management, LLC | 25,308 | $30.4K |
| American International Group, Inc. | 24,776 | $29.7K |
| Principal Financial Group Inc | 24,217 | $29.1K |
| STRS Ohio | 24,300 | $29.0K |
| Manufacturers Life Insurance Company, The | 22,560 | $27.1K |
| Voya Investment Management LLC | 19,953 | $23.9K |
| California State Teachers Retirement System | 19,086 | $22.9K |
| Invesco Ltd. | 16,863 | $20.2K |
| ProShare Advisors LLC | 13,597 | $16.3K |
| Newtyn Management, LLC | 12,937 | $15.5K |
| Cannell Capital LLC | 12,649 | $15.2K |
| Zacks Investment Management | 11,851 | $14.2K |
| SG Americas Securities, LLC | 11,262 | $14.0K |
| Amalgamated Bank | 5,333 | $6.00K |
| Legal & General Group Plc | 4,746 | $5.70K |
| Ameritas Investment Partners, Inc. | 4,566 | $5.48K |
| Ellevest, Inc. | 576 | $691 |
| Belpointe Asset Management LLC | 300 | $360 |
Not filed for Q2 2023 yet (1)
Institutions that held Invivyd, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 35,155 | $42.2K |